News stories from 2025
Paula’s journey on the Generation Study
Paula Kaya, from Erdington, is one of over 1,500 mothers to have taken part in the Generation Study at University Hospitals Birmingham, which tests newborns for more than 200 rare genetic conditions.
Birmingham to lead the way in testing promising new cystinosis treatment
Queen Elizabeth Hospital Birmingham (QEHB) will lead a new clinical trial, backed by nearly £4 million in funding, to test a drug discovered by an “inspirational” University of Sunderland scientist dedicated to improving the treatment of patients with a rare, life-threatening genetic disease.
New UK study to explore MRI screening as standard practice for detecting breast cancer that has spread to the brain
A new national research study, led by researchers at University Hospitals Birmingham (UHB) and The Clatterbridge Cancer Centre NHS Foundation Trust in Liverpool, has opened to investigate whether magnetic resonance imaging (MRI) screening should become standard practice for detecting breast cancer that has spread to the brain.
Latest findings offer hope for patients with rare skin cancer
Researchers at Queen Elizabeth Hospital Birmingham (QEHB), a leading centre for the PROCLIPI Study, have contributed to new findings showing that patients with Cutaneous (skin) T-cell Lymphoma (CTCL) experienced improved overall survival when treated with mogamulizumab, known by its brand name POTELIGEO.
1,000 newborn samples collected for The Generation Study at UHB
Research colleagues at UHB have recently reached a recruitment milestone in a national study aimed at identifying rare conditions earlier in newborns.
Birmingham locals to participate in first-of-its-kind study into impact of vaping on respiratory health
Researchers from University Hospitals Birmingham NHS Foundation Trust (UHB) and the University of Birmingham are leading a major new study to explore the potential benefits and harms of vaping on long-term respiratory health.